Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connick

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Neuroendocrinology|January 1, 1983
Extrahypothalamic brain luteinizing hormone: characterization by radioimmunoassay, chromatography, radioligand assay and bioassayN V Emanuele, J Anderson, E Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
In vivo effects of chicken myelomonocytic growth factor: delivery via a viral vectorJ J York, A D Strom, T E Connick, et al.
AIDS Research and Human Retroviruses|August 10, 1996
HIV-specific cellular and humoral immune responses in primary HIV infectionE Connick, D G Marr, X Q Zhang, et al.
AIDS Research and Human Retroviruses|September 18, 2001
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapyH Wu, E Connick, D R Kuritzkes, et al.
AIDS (London, England)|August 17, 1999
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infectionJ Andersson, H Behbahani, J Lieberman, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 TeamD R Kuritzkes, A Sevin, B Young, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 1999
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 TeamG H Friedland, R Pollard, B Griffith, et al.
The Journal of Infectious Diseases|December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapyK Y Smith, H Valdez, A Landay, et al.
AIDS (London, England)|July 23, 1999
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replicationA H Patki, S F Purvis, H Valdez, et al.
Clinical Immunology (Orlando, Fla.)|July 22, 1999
Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cellsS Kaushal, A L Landay, M M Lederman, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neuroendocrinology|January 1, 1983
Extrahypothalamic brain luteinizing hormone: characterization by radioimmunoassay, chromatography, radioligand assay and bioassayN V Emanuele, J Anderson, E Andersen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
In vivo effects of chicken myelomonocytic growth factor: delivery via a viral vectorJ J York, A D Strom, T E Connick, et al.
AIDS Research and Human Retroviruses|August 10, 1996
HIV-specific cellular and humoral immune responses in primary HIV infectionE Connick, D G Marr, X Q Zhang, et al.
AIDS Research and Human Retroviruses|September 18, 2001
Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapyH Wu, E Connick, D R Kuritzkes, et al.
AIDS (London, England)|August 17, 1999
Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infectionJ Andersson, H Behbahani, J Lieberman, et al.
The Journal of Infectious Diseases|February 11, 2000
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 TeamD R Kuritzkes, A Sevin, B Young, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 31, 1999
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 TeamG H Friedland, R Pollard, B Griffith, et al.
The Journal of Infectious Diseases|December 23, 1999
Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapyK Y Smith, H Valdez, A Landay, et al.
AIDS (London, England)|July 23, 1999
HIV infection perturbs DNA content of lymphoid cells: partial correction after 'suppression' of virus replicationA H Patki, S F Purvis, H Valdez, et al.
Clinical Immunology (Orlando, Fla.)|July 22, 1999
Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cellsS Kaushal, A L Landay, M M Lederman, et al.
Pageof 4